Viral Antigens, Inc Company Profile
VIRAL ANTIGENS, INC. was founded in September of 1982 to commercialize techniques for producing high quality antigens and viral components and attaching them to latex beads. Research on rubella virus at the University of Tennessee at Memphis led to the development of a novel test to detect rubella virus specific antibodies. The test was licensed to Becton Dickinson (BD) to market the product with VAI manufacturing the rubella coated latex beads. BD's Rubascan Test Kit was highly successful capturing 50% market share within the first three years. VAI went on to develop CMV and VZV coated latex beads to expand BD's product line.
Due to our reputation of high product quality, Viral Antigens, Inc. has grown to be a recognized leader in supplying standard and custom antigens to the majority of the leading diagnostic companies in the U.S.A. and around the world.
Location
5171 Wilfong Road
Memphis
Tennessee
38134
United States of America
Contact
Phone: 901.382.8716
Fax: 901.382.0027
Email: rstudholme@viralantigens.com
News Articles
Live Attenuated Rubella Vector to Express Vaccine Antigens
Live attenuated viruses make potent and effective vaccines. Despite the urgent need for an HIV vaccine, this approach has not been feasible because it has not been possible to attenuate the virus reli...
Spanish researchers design biomarkers for the detection of dengue and West Nile virus
(University of Granada) The spin-off of the University of Granada Rekom Biotech designs recombinant antigens useful for the identification of these two viral diseases, which affect millions of people...
Transmission-Blocking Malaria Vaccine
There is no vaccine for malaria, and there is growing resistance to existing anti-malarial drugs. Sexual stage-specific antigens are of interest as vaccine candidates because disruption of these anti...
Lonza completes new viral vaccine and gene therapy GMP suite
Lonza has completed its new GMP clean room within its Houston, Texas, USA operations which will support multiple types of viral vector and viral vaccine projects, with working volumes up to 2,000 litr...
In An Animal Model Of Ovarian Cancer, Engineered T Cells Kill Tumors But Spare Normal Tissue
The need to distinguish between normal cells and tumor cells is a feature that has been long sought for most types of cancer drugs. Tumor antigens, unique proteins on the surface of a tumor, are poten...
Cancer/testis antigens and urological malignancies
In this Review, Kulkarni and colleagues evaluate the available literature regarding the utility of cancer/testis antigens as biomarkers and therapeutic tools for patients with prostate, bladder, renal...
Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral Therapy
To the Editor: Antiretroviral therapy (ART) can be used to reduce human immunodeficiency virus (HIV) transmission. For this treatment-as-prevention strategy to be effective, patients must adhere to AR...
Recognition of CD1d-restricted antigens by natural killer T cells
Here, the authors discuss how the T cell receptors expressed by natural killer T cells are able to recognize and respond to an array of self and foreign lipid antigens that are presented on CD1d molec...
Drugs and Medications
Zovirax [BTA PHARMACEUTICALS INC]
ZOVIRAX (acyclovir) Ointment 5%
Zovirax [BTA PHARMACEUTICALS INC]
ZOVIRAX (acyclovir) Cream 5%USE ONLY FOR COLD SORES
Denavir [New American Therapeutics, Inc]
Denavir BRAND OF penciclovir cream, 1% For Dermatologic Use Only Rx only
Denavir [Novartis Consumer Health, Inc.]
Denavir
Denavir [Physicians Total Care, Inc.]
Denavir
PubMed Articles
Live attenuated viruses make potent and effective vaccines. Despite the urgent need for an HIV vaccine, this approach has not been feasible, since it has not been possible to attenuate the virus relia...
ABSTRACT: BACKGROUND: Endemic Burkitt's lymphoma (BL) is an extranodal tumor appearing predominantly in the jaw in younger children while abdominal tumors predominate with increasing age. Previous stu...
Immunofluorescence analyses of FMDV persistently infected BHK-21 cells showed that in cultures from early stages of the persistence (passage 15) only about 10% of cells displayed viral antigens, while...
Langerhans cells (LCs) are a subset of dendritic cells (DCs) that reside in the upper respiratory tract and are ideally suited to sense respiratory virus infections. Measles virus (MV) is a highly inf...
Naked DNA vaccines given by intramuscular injection are efficient in mouse models, but they require improvement for human use. As the immunogenicity of DNA vaccines depends, to a large extent, on the...
Clinical Trials
vaccination protocol to induce specific immune responses against melanoma associated antigens by intradermal injections of mRNA coding for the corresponding antigen
The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
The purpose of this study is to determine the number of newly formed CD4 cells in children who have taken anti-HIV drugs. The study will also evaluate the effectiveness of the new CD4 cel...
Histoblood Group Antigens as a Risk Factor of Asthma
This study will evaluate the link between blood group antigens and asthma exacerbations.
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
The proposed study will test the safety and efficacy of sodium valproate in the induction of Epstein-Barr virus (EBV) lytic cycle antigen expression in tumor tissue of patients undergoing...
The objective of this phase I/II therapeutic human immunodeficiency virus (HIV) vaccine candidate study is to provide proof of concept for a HIV antigen delivery system in terms of safety,...
Companies
VIRAL ANTIGENS, INC. was founded in September of 1982 to commercialize techniques for producing high quality antigens and viral components and attaching them to latex beads. Research on rubella virus...
VIROGEN Corporation is a leading provider of antigens and antibodies to the research and diagnostics markets. We are located in Greater Boston, a world center of science and technology. Founded in 199...
Established in 1995,Vybion, Inc. , formerly Viral Therapeutics, develops and manufactures recombinant proteins, including biotherapeutics, viral antigens, cellular proteins, cytokines, growth factors,...
Virus Detection & Diagnostics Virinova
Our unique and proprietory diagnostic technology enables the detection and quantification of viruses without the use of PCR or antibodies - Direct detection of viruses and viral particles - F...
ZeptoMetrix Corporation (ZMC) is a fully integrated biotechnology company that manufactures and distributes products for the research and biotechnology communities worldwide. Included in our state of...
More Information about "Viral Antigens, Inc" on BioPortfolio
We have published hundreds of Viral Antigens, Inc news stories on BioPortfolio along with dozens of Viral Antigens, Inc Clinical Trials and PubMed Articles about Viral Antigens, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Viral Antigens, Inc Companies in our database. You can also find out about relevant Viral Antigens, Inc Drugs and Medications on this site too.
